85 related articles for article (PubMed ID: 15802897)
1. The CX3C chemokine fractalkine (CX3CL1) is detectable in serum of B cell chronic lymphocytic leukemia patients with lymph node involvement.
Morabito F; Merendino RA; Penna G; Cuzzola M; Stelitano C; Callea V; Di Pasquale G; Minciullo PL; Gangemi S
Acta Haematol; 2005; 113(2):152-4. PubMed ID: 15802897
[No Abstract] [Full Text] [Related]
2. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea.
Gangemi S; Cannavò SP; Guarneri F; Merendino RA; Sturniolo GC; Minciullo PL; Di Pasquale G; Valenzise M; Drago F; Rebora A
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1366-7. PubMed ID: 17062081
[No Abstract] [Full Text] [Related]
3. Involvement of fractalkine and macrophage inflammatory protein-1 alpha in moderate-severe depression.
Merendino RA; Di Pasquale G; De Luca F; Di Pasquale L; Ferlazzo E; Martino G; Palumbo MC; Morabito F; Gangemi S
Mediators Inflamm; 2004 Jun; 13(3):205-7. PubMed ID: 15223613
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.
Bjerkeli V; Damås JK; Fevang B; Holter JC; Aukrust P; Frøland SS
Rheumatology (Oxford); 2007 Sep; 46(9):1422-7. PubMed ID: 17616549
[TBL] [Abstract][Full Text] [Related]
5. The CX3C chemokine fractalkine in allergic asthma and rhinitis.
Rimaniol AC; Till SJ; Garcia G; Capel F; Godot V; Balabanian K; Durand-Gasselin I; Varga EM; Simonneau G; Emilie D; Durham SR; Humbert M
J Allergy Clin Immunol; 2003 Dec; 112(6):1139-46. PubMed ID: 14657873
[TBL] [Abstract][Full Text] [Related]
6. Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis.
Matsunawa M; Isozaki T; Odai T; Yajima N; Takeuchi HT; Negishi M; Ide H; Adachi M; Kasama T
Arthritis Rheum; 2006 Nov; 54(11):3408-16. PubMed ID: 17075825
[TBL] [Abstract][Full Text] [Related]
7. The chemokine fractalkine in patients with severe traumatic brain injury and a mouse model of closed head injury.
Rancan M; Bye N; Otto VI; Trentz O; Kossmann T; Frentzel S; Morganti-Kossmann MC
J Cereb Blood Flow Metab; 2004 Oct; 24(10):1110-8. PubMed ID: 15529011
[TBL] [Abstract][Full Text] [Related]
8. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy.
Damås JK; Boullier A; Waehre T; Smith C; Sandberg WJ; Green S; Aukrust P; Quehenberger O
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2567-72. PubMed ID: 16224053
[TBL] [Abstract][Full Text] [Related]
9. Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis.
Hasegawa M; Sato S; Echigo T; Hamaguchi Y; Yasui M; Takehara K
Ann Rheum Dis; 2005 Jan; 64(1):21-8. PubMed ID: 15608300
[TBL] [Abstract][Full Text] [Related]
10. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
Lucas AD; Bursill C; Guzik TJ; Sadowski J; Channon KM; Greaves DR
Circulation; 2003 Nov; 108(20):2498-504. PubMed ID: 14581400
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.
Matsubara T; Ono T; Yamanoi A; Tachibana M; Nagasue N
J Surg Oncol; 2007 Mar; 95(3):241-9. PubMed ID: 17323338
[TBL] [Abstract][Full Text] [Related]
13. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.
Kastenbauer S; Koedel U; Wick M; Kieseier BC; Hartung HP; Pfister HW
J Neuroimmunol; 2003 Apr; 137(1-2):210-7. PubMed ID: 12667665
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis.
Blaschke S; Koziolek M; Schwarz A; Benöhr P; Middel P; Schwarz G; Hummel KM; Müller GA
J Rheumatol; 2003 Sep; 30(9):1918-27. PubMed ID: 12966591
[TBL] [Abstract][Full Text] [Related]
15. The high expression of Fractalkine results in a better prognosis for colorectal cancer patients.
Ohta M; Tanaka F; Yamaguchi H; Sadanaga N; Inoue H; Mori M
Int J Oncol; 2005 Jan; 26(1):41-7. PubMed ID: 15586223
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
17. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
[TBL] [Abstract][Full Text] [Related]
18. Carbonyl group serum levels are associated with CD38 expression in patients with B chronic lymphocytic leukemia.
Musolino C; Allegra A; Alonci A; Saija A; Russo S; Cannavò A; Cristani M; Centorrino R; Saitta S; Alibrandi A; Gangemi S
Clin Biochem; 2011 Dec; 44(17-18):1487-90. PubMed ID: 21945028
[TBL] [Abstract][Full Text] [Related]
19. Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus.
Sato E; Iikuni N; Yoshio T; Minota S; Kamatani N; Okamoto H
Ann Rheum Dis; 2006 Sep; 65(9):1257-9. PubMed ID: 16905589
[No Abstract] [Full Text] [Related]
20. Detection of elevated serum levels of the chemokine CCL18 in B-cell chronic lymphocytic leukaemia: identification of a novel biomarker.
Schröttner P; Wollner S; Catusse J; Burger M
Acta Haematol; 2010; 124(2):110-4. PubMed ID: 20733288
[No Abstract] [Full Text] [Related]
[Next] [New Search]